nent with 22% of patients having a nontherapeutic IR procedure in the first decade compared with 4% in the second decade. Better identification of patients with static MPS in the second decade while directing patients with pure dynamic MPS to immediate open repair contributed to a decrease in the rate of nontherapeutic IR. On the other hand, 21.4% (29/135) of patients died of organ failure before definite operative repair in spite of visceral or limb reperfusion. Such a finding suggests the presence of severe or possible irreversible organ dysfunction, rendering all forms of intervention futile. When further analyzing the causes of death in these 29 patients, the authors identify a significant brain injury in 12/29 (41.4%) patients. The treatment strategy in patients with combined cerebral and visceral MPS is complex and linked to a high mortality. According to the authors, in hemodynamically stable patients, priority should be given to upfront IR visceral reperfusion and definite aortic repair performed as soon as possible. However, it is well known that medical treatment in patients with cerebral MPS offers a dismal outcome. 2 In addition, in the interval before definite surgical repair, cerebral MPS attributable to an extension of the dissection process may occur and go unrecognized in a sedated patient.
When comparing expected outcomes calculated by previously published models, the authors did not show a survival benefit of their upfront IR strategy in patients with visceral/limb MPS. A mortality of 41% and 33% were reported in the 1st and 2nd decade, respectively, results comparable with the Leipzig-Halifax, Stockholm, Penn, and German Registry for Acute Aortic Dissection type A models. Improvement in hospital mortality between decades was secondary to a decrease from 16% to 4% in aortic rupture mainly attributed to meticulous blood pressure control, profound sedation, and earlier definite surgical therapy. Interestingly, overall survival after hospital discharge of patients with an upfront IR approach was similar to patients without MPS.
Management of type A dissection has evolved during the last decade. Operative strategies including cannulation site, cerebral protection techniques, and extent of repair using the frozen elephant trunk technique or distal bare stents are undergoing continued refinements and evaluation. Use of novel intraoperative cannulation approaches in patients with MPS has been reported. 3 In a retrospective analysis of 305 acute type A aortic dissection patients treated with an immediate open surgical repair and delayed endovascular stenting in patients with persistent MPS, the Stanford group reported an increased mortality only in patients with 3 MPS sites, whereas patients with 1 or 2 MPS sites showed a mortality comparable with patients without MPS. 4 Furthermore, the advent of hybrid rooms allows for intraoperative angiogram completion after aortic repair with concomitant endovascular treatment if ongoing ischemia is diagnosed. Surgical expertise and creation of aortic hubs have been demonstrated to decrease operative mortality in type A dissection. 5 Time to intervention and surgical and IR expertise are important considerations in selecting the initial appropriate therapy because delay in intervention impacts outcome, especially in high-risk patients with MPS. The work of Yang et al 1 supports the current efforts to improve outcomes in high-risk type A dissection. A multidisciplinary approach as proposed by the authors further strengthens the concept of an expert team for the management of complex aortic dissection cases. Further investigation is required to better define which patients with MPS could benefit from an upfront IR therapy as opposed to an immediate open repair.
